Amino Acids

pp 1–9 | Cite as

Knocking down raptor in human keratinocytes affects ornithine decarboxylase in a post-transcriptional Manner following ultraviolet B exposure

  • Coryn L. Stump
  • Robert P. Feehan
  • Torey Jordan
  • Lisa M. Shantz
  • Shannon L. NowotarskiEmail author
Original Article
Part of the following topical collections:
  1. Polyamines: Biochemical and Pathophysiological Properties


Non-melanoma skin cancer (NMSC) is the most common form of cancer. Ultraviolet-B (UVB) radiation has been shown to be a complete carcinogen in the development of NMSC. The mammalian target of rapamycin complex 1 (mTORC1) is upregulated by UVB. Ornithine decarboxylase (ODC), the first enzyme of the polyamine biosynthetic pathway, is also upregulated in response to UVB. However, the interplay between these two pathways after UVB exposure remains unclear. The studies described here compare mRNA stability between normal human keratinocytes (HaCaT cells) and HaCaT cells with low levels of raptor to investigate whether the induction of ODC by UVB is dependent on mTORC1. We show that the knockdown of mTORC1 activity led to decreased levels of ODC protein both before and after exposure to 20 mJ/cm2 UVB. ODC mRNA was less stable in cells with decreased mTORC1 activity. Polysome profiles revealed that the initiation of ODC mRNA translation did not change in UVB-treated cells. We have shown that the ODC transcript is stabilized by the RNA-binding protein human antigen R (HuR). To expand these studies, we investigated whether HuR functions to regulate ODC mRNA stability in human keratinocytes exposed to UVB. We show an increased cytoplasmic localization of HuR after UVB exposure in wild-type cells. The ablation of HuR via CRISPR/Cas9 did not alter the stability of the ODC message, suggesting the involvement of other trans-acting factors. These data suggest that in human keratinocytes, ODC mRNA stability is regulated, in part, by an mTORC1-dependent mechanism after UVB exposure.


Ornithine decarboxylase mTOR Post-transcriptional regulation mRNA stability 



The authors would like to thank Dr. Scot Kimball (Penn State College of Medicine) for his help with the polysome profiles. Work in the authors’ laboratory was funded by grants from the National Institutes of Health (ES19242 to LMS, ES26471 to RPF) and funds from Penn State Berks to SLN.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants performed by any of the authors. This article does not contain any studies with animals performed by any of the authors.

Informed consent

This article does not contain any studies with human participants performed by any of the authors.


  1. Alayev A, Holz MK (2013) mTOR signaling for biological control and cancer. J Cell Physiol 228(8):1658–1664. CrossRefGoogle Scholar
  2. American Cancer Society (2016) Cancer facts and figures 2016Google Scholar
  3. Bowden GT (2004) Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer 4(1):23–35. CrossRefGoogle Scholar
  4. Campistol JM, Eris J, Oberbauer R, Friend P, Hutchison B, Morales JM, Claesson K, Stallone G, Russ G, Rostaing L, Kreis H, Burke JT, Brault Y, Scarola JA, Neylan JF (2006) Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 17(2):581–589. CrossRefGoogle Scholar
  5. Carr TD, DiGiovanni J, Lynch CJ, Shantz LM (2012) Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival. Cancer Prev Res (Phila) 5(12):1394–1404. CrossRefGoogle Scholar
  6. Carr TD, Feehan RP, Hall MN, Ruegg MA, Shantz LM (2015) Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors. Carcinogenesis 36(4):487–497. CrossRefGoogle Scholar
  7. Casero RA Jr, Murray Stewart T, Pegg AE (2018) Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer 18(11):681–695. CrossRefGoogle Scholar
  8. Chen SJ, Nakahara T, Takahara M, Kido M, Dugu L, Uchi H, Takeuchi S, Tu YT, Moroi Y, Furue M (2009) Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2. Br J Dermatol 160(2):442–445. CrossRefGoogle Scholar
  9. Feehan RP, Shantz LM (2016) Negative regulation of the FOXO3a transcription factor by mTORC2 induces a pro-survival response following exposure to ultraviolet-B irradiation. Cell Signal 28(8):798–809. CrossRefGoogle Scholar
  10. Feehan RP, Nelson AM, Shantz LM (2018) Inhibition of mTORC2 enhances UVB-induced apoptosis in keratinocytes through a mechanism dependent on the FOXO3a transcriptional target NOXA but independent of TRAIL. Cell Signal 52:35–47. CrossRefGoogle Scholar
  11. Fernau NS, Fugmann D, Leyendecker M, Reimann K, Grether-Beck S, Galban S, Ale-Agha N, Krutmann J, Klotz LO (2010) Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional regulation of COX-2 expression in the human keratinocyte cell line HaCaT. J Biol Chem 285(6):3896–3904. CrossRefGoogle Scholar
  12. Gerner EW, Meyskens FL Jr (2004) Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4(10):781–792. CrossRefGoogle Scholar
  13. Gilmour SK (2007) Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 224(3):249–256. CrossRefGoogle Scholar
  14. Guan BJ, Krokowski D, Majumder M, Schmotzer CL, Kimball SR, Merrick WC, Koromilas AE, Hatzoglou M (2014) Translational control during endoplasmic reticulum stress beyond phosphorylation of the translation initiation factor eIF2a. J Biol Chem 289(18):12593–12611. CrossRefGoogle Scholar
  15. Huang K, Fingar DC (2014) Growing knowledge of the mTOR signaling network. Semin Cell Dev Biol 36:79–90. CrossRefGoogle Scholar
  16. Huang C, Li J, Ke Q, Leonard SS, Jiang BH, Zhong XS, Costa M, Castranova V, Shi X (2002) Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C. Cancer Res 62(20):5689–5697Google Scholar
  17. Kawai T, Fan J, Mazan-Mamczarz K, Gorospe M (2004) Global mRNA stabilization preferentially linked to translational repression during the endoplasmic reticulum stress response. Mol Cell Biol 24(15):6773–6787. CrossRefGoogle Scholar
  18. Kawai T, Lal A, Yang X, Galban S, Mazan-Mamczarz K, Gorospe M (2006) Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR. Mol Cell Biol 26(8):3295–3307. CrossRefGoogle Scholar
  19. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274–293. CrossRefGoogle Scholar
  20. Madan V, Lear JT, Szeimies RM (2010) Non-melanoma skin cancer. Lancet 375(9715):673–685. CrossRefGoogle Scholar
  21. Nowotarski SL, Shantz LM (2010) Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model. J Biol Chem 285(41):31885–31894. CrossRefGoogle Scholar
  22. Nowotarski SL, Woster PM, Casero RA Jr (2013) Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med 15:e3. CrossRefGoogle Scholar
  23. Nowotarski SL, Feith DJ, Shantz LM (2015) Skin carcinogenesis studies using mouse models with altered polyamines. Cancer Growth Metastasis 8(Suppl 1):17–27. Google Scholar
  24. Nowotarski SL, Feehan RP, Presloid C, Shantz LM (2018) Knockout of Raptor destabilizes ornithine decarboxylase mRNA and decreases binding of HuR to the ODC transcript in cells exposed to ultraviolet-B irradiation. Biochem Biophys Res Commun 505(4):1022–1026. CrossRefGoogle Scholar
  25. O’Brien TG (1976) The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 36(7 PT 2):2644–2653Google Scholar
  26. O’Brien TG, Megosh LC, Gilliard G, Soler AP (1997) Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res 57(13):2630–2637Google Scholar
  27. Origanti S, Shantz LM (2007) Ras transformation of RIE-1 cells activates cap-independent translation of ornithine decarboxylase: regulation by the Raf/MEK/ERK and phosphatidylinositol 3-kinase pathways. Cancer Res 67(10):4834–4842. CrossRefGoogle Scholar
  28. Origanti S, Nowotarski SL, Carr TD, Sass-Kuhn S, Xiao L, Wang JY, Shantz LM (2012) Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells. Biochem J 442(1):199–207. CrossRefGoogle Scholar
  29. Patrick MH (1977) Studies on thymine-derived UV photoproducts in DNA—I. Formation and biological role of pyrimidine adducts in DNA. Photochem Photobiol 25(4):357–372CrossRefGoogle Scholar
  30. Patursky-Polischuk I, Stolovich-Rain M, Hausner-Hanochi M, Kasir J, Cybulski N, Avruch J, Ruegg MA, Hall MN, Meyuhas O (2009) The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner. Mol Cell Biol 29(3):640–649. CrossRefGoogle Scholar
  31. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2000. Arch Dermatol 146(3):283–287. CrossRefGoogle Scholar
  32. Rosen CF, Gajic D, Drucker DJ (1990a) Ultraviolet radiation induction of ornithine decarboxylase in rat keratinocytes. Cancer Res 50(9):2631–2635Google Scholar
  33. Rosen CF, Gajic D, Jia Q, Drucker DJ (1990b) Ultraviolet B radiation induction of ornithine decarboxylase gene expression in mouse epidermis. Biochem J 270(3):565–568CrossRefGoogle Scholar
  34. Shantz LM (2004) Transcriptional and translational control of ornithine decarboxylase during Ras transformation. Biochem J 377(Pt 1):257–264CrossRefGoogle Scholar
  35. Zabala-Letona A, Arruabarrena-Aristorena A, Martin-Martin N, Fernandez-Ruiz S, Sutherland JD, Clasquin M, Tomas-Cortazar J, Jimenez J, Torres I, Quang P, Ximenez-Embun P, Bago R, Ugalde-Olano A, Loizaga-Iriarte A, Lacasa-Viscasillas I, Unda M, Torrano V, Cabrera D, van Liempd SM, Cendon Y, Castro E, Murray S, Revandkar A, Alimonti A, Zhang Y, Barnett A, Lein G, Pirman D, Cortazar AR, Arreal L, Prudkin L, Astobiza I, Valcarcel-Jimenez L, Zuniga-Garcia P, Fernandez-Dominguez I, Piva M, Caro-Maldonado A, Sanchez-Mosquera P, Castillo-Martin M, Serra V, Beraza N, Gentilella A, Thomas G, Azkargorta M, Elortza F, Farras R, Olmos D, Efeyan A, Anguita J, Munoz J, Falcon-Perez JM, Barrio R, Macarulla T, Mato JM, Martinez-Chantar ML, Cordon-Cardo C, Aransay AM, Marks K, Baselga J, Tabernero J, Nuciforo P, Manning BD, Marjon K, Carracedo A (2017) mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. Nature 547(7661):109–113. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of ScienceThe Pennsylvania State University Berks CampusReadingUSA
  2. 2.Department of Cellular and Molecular PhysiologyThe Pennsylvania State University College of MedicineHersheyUSA

Personalised recommendations